drugset / Trial / NCT06724549

The Effect of Food on the Pharmacokinetics of BN104 Tablets

NCT06724549

Phase 1 Completed 16 enrolled BioNova Pharmaceuticals (Shanghai) LTD.
RandomizedCrossoverOpen-labelTreatment

Summary

The goal of the clinical trial is to evaluate the effect of food on the Pharmacokinetics of BN104 tablets in healthy subjects. The main questions it aims to answer are: Whether the pharmacokinetic characteristics of BN104 tablets will be affected by food? How well is the safety and tolerability of BN104 tablets in healthy subjects? To preliminarily evaluate the effect of BN104 on the QTc interval.

Timeline

Start
2025-01-12
Primary completion
2025-02-13
Completion
2025-02-13

Drugs

EvaluationDrugModalityDoseRoute
Comparator BN104 Small molecule 600 mg

Indications

No indication recorded.